Wortmannin (SL-2052): Mechanism of Action

Wortmannin (SL-2052) MOA:Targeting PI3K/PI3K-AKT-mTOR Pathway for Oncology Research

🎯 check Wortmannin (SL-2052) product page

Wortmannin (SL-2052) is a potent, irreversible, and noncompetitive PI3K inhibitor. It affects the PI3K/Akt/mTOR signaling pathway by binding to the p110 catalytic subunit, effectively inhibiting autophagy, cell proliferation, and migration, while promoting apoptosis.

Primary Applications and Mechanism of Action